« Previous
Next »
Journal of Pain and Symptom Management
Volume 38, Issue 6
, Pages 894-902
, December 2009
Genetic and Nongenetic Covariates of Pain Severity in Patients with Adenocarcinoma of the Pancreas: Assessing the Influence of Cytokine Genes
References
- Characterization of cytokine-induced hyperalgesia. Brain Res. 1994;654:15–26
- . Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sci. 1995;57:1011–1026
- . Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 1995;63:289–302
- . Implications of immune-to-brain communication for sickness and pain. Proc Natl Acad Sci USA. 1999;96:7710–7713
- . Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv Exp Med Biol. 2003;521:1–21
- . Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med. 2005;257:139–155
- Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci. 2001;21:5027–5035
- Cytokine genes and pain severity in lung cancer: exploring the influence of TNF-{alpha}-308 G/A IL6-174G/C and IL8-251T/A. Cancer Epidemiol Biomarkers Prev. 2007;16:2745–2751
- . An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain. 1999;82:263–274
- . Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma. Qual Life Res. 2004;13:1369–1379
- . Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56:899–905
- . A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–233
- . Long-term quality of life after total laryngectomy. Head Neck. 2006;28:313–320
- National Cancer Institute, Cancer Genome Anatomy Project SNP500 Cancer Database. 2007. Available from: http://snp500cancer.nci.nih.gov.
- NCCN practice guidelines for cancer pain. Oncology (Williston Park). 2000;14:135–150
- . Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96:434–442
- . Impact of IL8 and IL8-receptor alpha polymorphisms on the genetics of bronchial asthma and severe RSV infections. Clin Mol Allergy. 2006;4:2
- . Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica. Eur Spine J. 2002;11:62–66
- . Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer. 2004;101:2727–2736
- A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci USA. 2005;102:1755–1760
- Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol. 2000;387:111–118
- Cerebrospinal fluid interleukin 8 concentrations and the subsequent development of postherpetic neuralgia. Am J Med. 2004;116:318–324
- . Postoperative pain, morphine consumption, and genetic polymorphism of IL-1beta and IL-1 receptor antagonist. Neurosci Lett. 2006;404:154–158
- Interleukin-1alphabeta gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain. Behav Brain Res. 2006;167:355–364
- . Association between interleukin 1-beta promoter (-511) polymorphism and depressive symptoms in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 2004;124:50–53
- Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain. Neuron Glia Biol. 2006;2:293–308
- Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain. 2006;126:294–308
- Replicating genotype-phenotype associations. Nature. 2007;447:655–660
- Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol. 2008;9:777–785
This work was supported by Public Health Service grants CA109043 and CA128069 from the National Cancer Institute. Patient consent and acquisition of blood specimens were supported by the Various Donor Fund for Pancreatic Cancer Research and National Institutes of Health grant CA101936 (SPORE in Pancreatic Cancer), The Texas Medical Center Genetics Consortium, and the Center for Clinical and Translational Sciences of the University of Texas Health Science Center at Houston.
PII: S0885-3924(09)00597-1
doi: 10.1016/j.jpainsymman.2009.04.019
© 2009 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Pain and Symptom Management
Volume 38, Issue 6
, Pages 894-902
, December 2009
